| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |